STAGE I LUNG CANCER AJCC V8

This study tests whether adding an immunotherapy drug called atezolizumab to standard radiation therapy helps people with early-stage non-small cell lung cancer live longer. About 415 participants with stage I-IIA lung cancer will receive either radiation alone or radiation plus …

This study tests whether adding the immunotherapy drug atezolizumab to standard chemoradiation helps people with limited stage small cell lung cancer live longer. About 544 participants will receive either chemoradiation alone or chemoradiation plus atezolizumab. The goal is to s…

This study compares two treatments for lung tumors: microwave ablation (using heat to kill cancer cells) and surgical wedge resection (removing a small piece of lung). It includes adults with non-small cell lung cancer, sarcoma, or colorectal cancer that has spread to the lungs. …

This early-stage trial tests a drug called NBTXR3 that makes radiation more effective at killing cancer cells. It is for people with non-small cell lung cancer that has returned and cannot be removed with surgery. The study aims to find the safest dose and see if combining the dr…

This study compares two treatments for early-stage non-small cell lung cancer: targeted radiation alone versus radiation plus the immunotherapy drug nivolumab. About 140 adults with stage I-IIA or recurrent lung cancer will participate. The goal is to see if adding immunotherapy …

This study tests an online program designed to help women with lung cancer feel more supported and less distressed during treatment. The program uses techniques like mindfulness and emotional processing to improve social well-being. About 70 women with stage I-IV non-small cell l…

This study tests a telehealth self-management program for people who have finished treatment for early-stage lung or colorectal cancer. The program provides coaching on follow-up care, communication with doctors, and quality of life. Researchers will compare outcomes between part…

This study is testing a low-literacy conversation tool designed to help people with lung cancer and their doctors make treatment decisions together. About 98 adults with non-small cell lung cancer will use the tool and report on their anxiety, decision confidence, and satisfactio…

This study aims to find out why some cancer patients develop nerve damage (tingling or numbness in hands and feet) from taxane chemotherapy. Researchers will track over 1,300 people with breast, lung, or ovarian cancer to see how age, gender, and other factors affect their risk. …